203 related articles for article (PubMed ID: 32988406)
1. Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE.
Kurte M; Vega-Letter AM; Luz-Crawford P; Djouad F; Noël D; Khoury M; Carrión F
Stem Cell Res Ther; 2020 Sep; 11(1):416. PubMed ID: 32988406
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles.
Hwang S; Sung DK; Kim YE; Yang M; Ahn SY; Sung SI; Chang YS
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003458
[TBL] [Abstract][Full Text] [Related]
3. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
[TBL] [Abstract][Full Text] [Related]
4. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.
Waterman RS; Tomchuck SL; Henkle SL; Betancourt AM
PLoS One; 2010 Apr; 5(4):e10088. PubMed ID: 20436665
[TBL] [Abstract][Full Text] [Related]
5. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
6. TLR3 or TLR4 Activation Enhances Mesenchymal Stromal Cell-Mediated Treg Induction via Notch Signaling.
Rashedi I; Gómez-Aristizábal A; Wang XH; Viswanathan S; Keating A
Stem Cells; 2017 Jan; 35(1):265-275. PubMed ID: 27571579
[TBL] [Abstract][Full Text] [Related]
7. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor.
Yan H; Wu M; Yuan Y; Wang ZZ; Jiang H; Chen T
Biochem Biophys Res Commun; 2014 May; 448(2):212-7. PubMed ID: 24780395
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
9. A Study of the Immunoregulatory Function of TLR3 and TLR4 on Mesenchymal Stem Cells in Ankylosing Spondylitis.
Li Y; Huang L; Cai Z; Deng W; Wang P; Su H; Wu Y; Shen H
Stem Cells Dev; 2019 Oct; 28(20):1398-1412. PubMed ID: 31456484
[TBL] [Abstract][Full Text] [Related]
10. Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
Dang S; Xu H; Xu C; Cai W; Li Q; Cheng Y; Jin M; Wang RX; Peng Y; Zhang Y; Wu C; He X; Wan B; Zhang Y
Autophagy; 2014 Jul; 10(7):1301-15. PubMed ID: 24905997
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell and endothelial progenitor cells coinjection improves LPS-induced lung injury via Tie2 activation and downregulation of the TLR4/MyD88 pathway.
Hoseinnia S; Ghane M; Norouzi J; Hosseini F
J Cell Biochem; 2021 Dec; 122(12):1791-1804. PubMed ID: 34397115
[TBL] [Abstract][Full Text] [Related]
12. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor activation regulates the paracrine effect of adipose-derived mesenchymal stem cells on reversing osteoarthritic phenotype of chondrocytes.
Wan Z; Wang X; Fu Z; Ma Y; Dai G; Gong X; Chen G; Yang L
Mol Biol Rep; 2024 Apr; 51(1):550. PubMed ID: 38642183
[TBL] [Abstract][Full Text] [Related]
14. TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling.
He X; Wang H; Jin T; Xu Y; Mei L; Yang J
PLoS One; 2016; 11(3):e0149876. PubMed ID: 26930594
[TBL] [Abstract][Full Text] [Related]
15. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
[TBL] [Abstract][Full Text] [Related]
16. Netrin-1 prolongs skin graft survival by inducing the transformation of mesenchymal stem cells from pro-rejection to immune-tolerant phenotype.
Liu LP; Chen W; Fan Y; Qi BY; Wang Z; Shi BY
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8741-8750. PubMed ID: 31696460
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt.
Wang ZJ; Zhang FM; Wang LS; Yao YW; Zhao Q; Gao X
Cell Biol Int; 2009 Jun; 33(6):665-74. PubMed ID: 19376254
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W
Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349
[TBL] [Abstract][Full Text] [Related]
19. Toll like receptor 3 & 4 responses of human turbinate derived mesenchymal stem cells: stimulation by double stranded RNA and lipopolysaccharide.
Hwang SH; Cho HK; Park SH; Lee W; Lee HJ; Lee DC; Oh JH; Park SH; Kim TG; Sohn HJ; Kang JM; Kim SW
PLoS One; 2014; 9(7):e101558. PubMed ID: 25004159
[TBL] [Abstract][Full Text] [Related]
20. Genetically Engineered Mesenchymal Stem Cell Therapy Against Murine Experimental Autoimmune Encephalomyelitis.
Rostami M; Haidari K; Amini H; Shahbazi M
Mol Neurobiol; 2022 Jun; 59(6):3449-3457. PubMed ID: 35325396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
